AI assistant
USCOM LIMITED — Major Shareholding Notification 2012
Jul 19, 2012
65979_rns_2012-07-19_02dbdd55-9ca5-4d2c-ab04-51eb7ed4049c.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au
M A R K E T A N N O U N C E M E N T
New substantial shareholding announced to market
Friday 20th of July 2012: Uscom (ASX code: UCM).
Uscom Ltd was today notified that Dr Stephen Woodford now holds 2,721,475 shares or 5.03% of the Company’s 54,124,488 issued fully paid ordinary stock.
Dr Stephen Woodford is a Private Anaesthetist and Research Physiologist working through The Brisbane Waters Private Hospital and the Australian School of Advanced Medicine (ASAM) at Macquarie University. Dr Woodford will be presenting results of his cardiovascular research at the American Society of Anesthesiology meeting in Washington in October, 2012. Dr Woodford bought his first USCOM device last year and has continued using the device in clinical practice whilst building his stake in the Company.
Dr Woodford said “I like the Company and I like the technology and I see it as a sound commercial opportunity; this is a great Company which is undervalued. Cardiovascular medicine has the potential for many improvements and Uscom is a company poised to lead these changes.”
Executive Chairman of Uscom, Rob Phillips said, “Dr Woodford is a highly respected clinician and researcher and understands the technology and the benefits it can deliver. He is also a shrewd investor who understands the corporate medical device environment. We welcome him to the Company as a substantial shareholder and look forward to the value his presence on the register will add.”
Uscom will release the initial substantial shareholder notice as soon as it is received from the shareholder.
About Uscom
Uscom Limited is an Australian medical device company which listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency and Intensive Care Medicine and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of fluid therapy.
USCOM has global regulatory approval and the device is currently marketed in North America, South America, Europe, the Middle East, Australia & New Zealand, China and SE Asia.
Uscom Contacts
Rob Phillips Executive Chairman [email protected]
Tom Rowe Company Secretary [email protected]